Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 13 | 2024 | 62 | 3.340 |
Why?
|
| Critical Care | 10 | 2022 | 46 | 2.790 |
Why?
|
| Health Care Rationing | 4 | 2020 | 16 | 1.830 |
Why?
|
| Hip Fractures | 4 | 2023 | 7 | 1.690 |
Why?
|
| Critical Illness | 7 | 2024 | 42 | 1.620 |
Why?
|
| Quality of Life | 4 | 2024 | 170 | 1.610 |
Why?
|
| Triage | 4 | 2020 | 11 | 1.410 |
Why?
|
| Patient Admission | 2 | 2019 | 11 | 1.340 |
Why?
|
| Osteoporotic Fractures | 2 | 2020 | 7 | 1.310 |
Why?
|
| Humans | 44 | 2024 | 14077 | 1.080 |
Why?
|
| Anti-Bacterial Agents | 5 | 2022 | 274 | 1.060 |
Why?
|
| Survivors | 1 | 2024 | 5 | 0.940 |
Why?
|
| South Africa | 25 | 2024 | 7312 | 0.930 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 12 | 0.920 |
Why?
|
| Anxiety | 1 | 2024 | 39 | 0.910 |
Why?
|
| Developing Countries | 2 | 2024 | 385 | 0.880 |
Why?
|
| Maternal Health Services | 1 | 2024 | 51 | 0.880 |
Why?
|
| Depression | 1 | 2024 | 117 | 0.840 |
Why?
|
| Aftercare | 1 | 2022 | 10 | 0.800 |
Why?
|
| Telemedicine | 1 | 2022 | 25 | 0.780 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 3 | 0.780 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 29 | 0.760 |
Why?
|
| Withholding Treatment | 4 | 2014 | 26 | 0.720 |
Why?
|
| Osteoporosis | 1 | 2020 | 14 | 0.710 |
Why?
|
| Adult | 17 | 2024 | 5664 | 0.680 |
Why?
|
| Pandemics | 4 | 2024 | 280 | 0.660 |
Why?
|
| Female | 23 | 2024 | 8751 | 0.610 |
Why?
|
| Sepsis | 4 | 2022 | 101 | 0.610 |
Why?
|
| Respiration, Artificial | 2 | 2014 | 46 | 0.570 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 2 | 0.570 |
Why?
|
| Preoperative Care | 1 | 2017 | 8 | 0.560 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 13 | 0.560 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 21 | 0.560 |
Why?
|
| Aged | 7 | 2024 | 1650 | 0.530 |
Why?
|
| Incidence | 5 | 2021 | 655 | 0.520 |
Why?
|
| Male | 13 | 2024 | 6489 | 0.520 |
Why?
|
| Benchmarking | 1 | 2014 | 10 | 0.460 |
Why?
|
| Middle Aged | 8 | 2024 | 3425 | 0.460 |
Why?
|
| Prospective Studies | 7 | 2024 | 1131 | 0.450 |
Why?
|
| Health Expenditures | 1 | 2014 | 34 | 0.450 |
Why?
|
| Biomedical Research | 1 | 2014 | 48 | 0.450 |
Why?
|
| Pregnancy Complications | 3 | 2018 | 53 | 0.420 |
Why?
|
| Hospitals, Private | 1 | 2012 | 8 | 0.410 |
Why?
|
| Acute Kidney Injury | 2 | 2022 | 15 | 0.400 |
Why?
|
| Pregnancy | 11 | 2024 | 1815 | 0.400 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 42 | 0.390 |
Why?
|
| Bacterial Infections | 1 | 2012 | 53 | 0.390 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 449 | 0.380 |
Why?
|
| Blood Culture | 2 | 2021 | 11 | 0.380 |
Why?
|
| Retrospective Studies | 5 | 2021 | 767 | 0.360 |
Why?
|
| Antihypertensive Agents | 2 | 2001 | 61 | 0.360 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 230 | 0.360 |
Why?
|
| Pre-Eclampsia | 2 | 2001 | 56 | 0.350 |
Why?
|
| Age Distribution | 2 | 2021 | 106 | 0.340 |
Why?
|
| Consensus | 2 | 2019 | 59 | 0.330 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2013 | 507 | 0.320 |
Why?
|
| Emergency Service, Hospital | 3 | 2021 | 37 | 0.270 |
Why?
|
| Public Health | 2 | 2020 | 122 | 0.270 |
Why?
|
| HIV Infections | 6 | 2021 | 4946 | 0.250 |
Why?
|
| Decision Making | 2 | 2014 | 52 | 0.230 |
Why?
|
| Prevalence | 2 | 2021 | 1149 | 0.230 |
Why?
|
| Cefazolin | 1 | 2023 | 2 | 0.220 |
Why?
|
| Escherichia coli | 1 | 2023 | 30 | 0.220 |
Why?
|
| Prenatal Care | 2 | 2008 | 141 | 0.220 |
Why?
|
| Hospital Mortality | 4 | 2021 | 94 | 0.220 |
Why?
|
| Candidiasis, Invasive | 1 | 2023 | 3 | 0.220 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 102 | 0.210 |
Why?
|
| Candidemia | 1 | 2023 | 13 | 0.210 |
Why?
|
| Risk Factors | 3 | 2021 | 1431 | 0.210 |
Why?
|
| Congresses as Topic | 4 | 2014 | 20 | 0.210 |
Why?
|
| Patient Discharge | 1 | 2022 | 27 | 0.200 |
Why?
|
| Patient Acuity | 1 | 2021 | 18 | 0.190 |
Why?
|
| Inosine Monophosphate | 1 | 2021 | 3 | 0.190 |
Why?
|
| Fungi | 1 | 2021 | 4 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 68 | 0.190 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 22 | 0.190 |
Why?
|
| Bacteria | 1 | 2021 | 46 | 0.190 |
Why?
|
| Length of Stay | 1 | 2021 | 43 | 0.190 |
Why?
|
| Magnesium Sulfate | 1 | 2000 | 3 | 0.180 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 243 | 0.170 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 128 | 0.170 |
Why?
|
| Medication Adherence | 1 | 2021 | 137 | 0.170 |
Why?
|
| Bone Density | 1 | 2020 | 103 | 0.170 |
Why?
|
| Quality of Health Care | 1 | 1999 | 58 | 0.160 |
Why?
|
| Africa | 1 | 2020 | 360 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 70 | 0.160 |
Why?
|
| Ketosis | 1 | 2018 | 2 | 0.160 |
Why?
|
| Acidosis | 1 | 2018 | 2 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 102 | 0.160 |
Why?
|
| Creatinine | 3 | 2023 | 51 | 0.160 |
Why?
|
| Child | 1 | 2024 | 2180 | 0.150 |
Why?
|
| Risk | 1 | 2017 | 87 | 0.150 |
Why?
|
| Sex Distribution | 1 | 2017 | 89 | 0.150 |
Why?
|
| Terminal Care | 2 | 2014 | 34 | 0.150 |
Why?
|
| Anti-Retroviral Agents | 1 | 2021 | 542 | 0.140 |
Why?
|
| Eclampsia | 3 | 2001 | 6 | 0.140 |
Why?
|
| APACHE | 2 | 2010 | 12 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2014 | 532 | 0.120 |
Why?
|
| Ventilator Weaning | 1 | 2014 | 2 | 0.120 |
Why?
|
| Morals | 1 | 2014 | 5 | 0.120 |
Why?
|
| Financial Audit | 1 | 2014 | 1 | 0.120 |
Why?
|
| Research Support as Topic | 1 | 2014 | 6 | 0.120 |
Why?
|
| Financing, Government | 1 | 2014 | 11 | 0.120 |
Why?
|
| HELLP Syndrome | 2 | 2006 | 3 | 0.110 |
Why?
|
| Age Factors | 1 | 2014 | 364 | 0.110 |
Why?
|
| Health Policy | 1 | 2014 | 132 | 0.110 |
Why?
|
| Adolescent | 4 | 2022 | 2858 | 0.110 |
Why?
|
| HIV-1 | 1 | 2021 | 1239 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2012 | 8 | 0.100 |
Why?
|
| Drug Resistance, Microbial | 1 | 2012 | 25 | 0.100 |
Why?
|
| Young Adult | 4 | 2022 | 2357 | 0.100 |
Why?
|
| Hospitals, Public | 1 | 2012 | 44 | 0.100 |
Why?
|
| Guideline Adherence | 1 | 2012 | 42 | 0.100 |
Why?
|
| Prognosis | 2 | 2022 | 197 | 0.090 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2001 | 3 | 0.090 |
Why?
|
| Africa, Southern | 2 | 2020 | 89 | 0.090 |
Why?
|
| Early Diagnosis | 2 | 2022 | 80 | 0.090 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2008 | 8 | 0.080 |
Why?
|
| Fluid Therapy | 1 | 2008 | 24 | 0.080 |
Why?
|
| Cross Infection | 1 | 2008 | 49 | 0.080 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 112 | 0.070 |
Why?
|
| ROC Curve | 2 | 2021 | 47 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 1377 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2006 | 13 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2006 | 20 | 0.070 |
Why?
|
| Hospitalization | 2 | 2021 | 392 | 0.060 |
Why?
|
| Life Support Care | 2 | 2014 | 10 | 0.060 |
Why?
|
| Time Factors | 2 | 2006 | 503 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2023 | 43 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2013 | 1410 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2023 | 40 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 8 | 0.050 |
Why?
|
| Imipenem | 1 | 2022 | 6 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2022 | 21 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 61 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 184 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2022 | 53 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2023 | 107 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2001 | 14 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 78 | 0.050 |
Why?
|
| Labor, Induced | 1 | 2001 | 24 | 0.050 |
Why?
|
| Central Venous Pressure | 1 | 2001 | 2 | 0.050 |
Why?
|
| Placental Circulation | 1 | 2001 | 6 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2001 | 20 | 0.050 |
Why?
|
| Fetal Monitoring | 1 | 2001 | 13 | 0.050 |
Why?
|
| Hospitals | 1 | 2021 | 102 | 0.050 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 18 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 111 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2021 | 132 | 0.050 |
Why?
|
| Acute Disease | 1 | 2021 | 105 | 0.050 |
Why?
|
| Biomarkers | 1 | 2022 | 322 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 210 | 0.050 |
Why?
|
| Global Health | 1 | 2001 | 183 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2000 | 4 | 0.040 |
Why?
|
| Recurrence | 1 | 2000 | 27 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2023 | 867 | 0.040 |
Why?
|
| Resource Allocation | 1 | 2020 | 16 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2000 | 149 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 380 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2000 | 4 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 51 | 0.040 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1999 | 2 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2000 | 73 | 0.040 |
Why?
|
| Syphilis | 1 | 1999 | 14 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2018 | 1 | 0.040 |
Why?
|
| Early Medical Intervention | 1 | 2018 | 7 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2018 | 106 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 808 | 0.040 |
Why?
|
| Ethics, Medical | 1 | 2014 | 11 | 0.030 |
Why?
|
| Advance Directives | 1 | 2014 | 2 | 0.030 |
Why?
|
| Bioethical Issues | 1 | 2014 | 4 | 0.030 |
Why?
|
| Apgar Score | 1 | 2013 | 8 | 0.030 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2013 | 17 | 0.030 |
Why?
|
| Maternal Death | 1 | 2013 | 25 | 0.030 |
Why?
|
| Birth Weight | 1 | 2013 | 78 | 0.030 |
Why?
|
| Ipratropium | 1 | 1991 | 2 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 1991 | 10 | 0.020 |
Why?
|
| Calibration | 1 | 2010 | 2 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 654 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 64 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 25 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 217 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2006 | 30 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2000 | 4 | 0.010 |
Why?
|
| Medical Records | 1 | 2000 | 22 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2000 | 16 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 37 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 183 | 0.010 |
Why?
|
| Logistic Models | 1 | 2000 | 252 | 0.010 |
Why?
|
| Bronchial Spasm | 1 | 1991 | 1 | 0.010 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1991 | 2 | 0.010 |
Why?
|
| Aerosols | 1 | 1991 | 7 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 25 | 0.010 |
Why?
|
| Random Allocation | 1 | 1991 | 23 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1991 | 1675 | 0.000 |
Why?
|
| Infant | 1 | 1991 | 2145 | 0.000 |
Why?
|